Publication
IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis
dc.contributor.author | Cravo, Marília | |
dc.contributor.author | Ferreira, P. A. | |
dc.contributor.author | Sousa, P. | |
dc.contributor.author | Santos, Paula Moura dos | |
dc.contributor.author | Velho, S. | |
dc.contributor.author | Tavares, Lourdes | |
dc.contributor.author | de Deus, J. R. | |
dc.contributor.author | Ministro, P. | |
dc.contributor.author | Peixe, P. | |
dc.contributor.author | Correia, L. A. | |
dc.contributor.author | Velosa, J. F. | |
dc.contributor.author | Maio, R. F. | |
dc.contributor.author | Brito, Miguel | |
dc.date.accessioned | 2014-01-03T21:30:55Z | |
dc.date.available | 2014-01-03T21:30:55Z | |
dc.date.issued | 2014-01 | |
dc.description.abstract | Objective - We aimed to identify the clinical and genetic [IL23 receptor (IL23R) single nucleotide polymorphisms (SNPs)] predictors of response to therapy in patients with ulcerative colitis. Patients and methods - A total of 174 patients with ulcerative colitis, 99 women and 75 men, were included. The mean age of the patients was 47±15 years and the mean disease duration was 11±9 years. The number of patients classified as responders (R) or nonresponders (NR) to several therapies was as follows: 110 R and 53 NR to mesalazine (5-ASA), 28 R and 20 NR to azathioprine (AZT), 18 R and 7 NR to infliximab. Clinical and demographic variables were recorded. A total of four SNPs were studied: IL23R G1142A, C2370A, G43045A, and G9T. Genotyping was performed by real-time PCR using Taqman probes. Results - Older patients were more prone to respond to 5-ASA (P=0.004), whereas those with pancolitis were less likely to respond to such therapies (P=0.002). Patients with extraintestinal manifestations (EIMs) were less likely to respond to 5-ASA (P=0.001), AZT (P=0.03), and corticosteroids (P=0.06). Carriers of the mutant allele for IL23R SNPs had a significantly higher probability of developing EIMs (P<0.05), a higher probability of being refractory to 5-ASA (P<0.03), but a higher likelihood of responding to AZT (P=0.05). A significant synergism was observed between IL23R C2370A and EIMs with respect to nonresponse to 5-ASA (P=0.03). Conclusion - Besides extent of disease and age at disease onset, the presence of EIMs may be a marker of refractoriness to 5-ASA, corticosteroids, and AZT. IL23R SNPs are associated both with EIMs and with nonresponse to 5-ASA and corticosteroids. | por |
dc.identifier.citation | Cravo ML, Ferreira PA, Sousa P, Moura-Santos P, Velho S, Brito M, et al. IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 2014;26(1):26-32. | por |
dc.identifier.issn | 1473-5687 | |
dc.identifier.uri | http://hdl.handle.net/10400.21/3065 | |
dc.language.iso | eng | por |
dc.peerreviewed | yes | por |
dc.publisher | Lippincott Williams & Wilkins | por |
dc.subject | IL23R polymorphisms | por |
dc.subject | Ulcerative colitis | por |
dc.subject | Single nucleotide polymorphisms | por |
dc.title | IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis | por |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 32 | por |
oaire.citation.startPage | 26 | por |
oaire.citation.title | European Journal of Gastroenterology & Hepatology | por |
oaire.citation.volume | 26 | por |
person.familyName | Brito | |
person.givenName | Miguel | |
person.identifier.ciencia-id | 231F-F341-7E93 | |
person.identifier.orcid | 0000-0001-6394-658X | |
person.identifier.rid | A-7970-2016 | |
person.identifier.scopus-author-id | 35224551000 | |
rcaap.rights | restrictedAccess | por |
rcaap.type | article | por |
relation.isAuthorOfPublication | 4252d8e0-800c-4d67-8b13-0b711d860669 | |
relation.isAuthorOfPublication.latestForDiscovery | 4252d8e0-800c-4d67-8b13-0b711d860669 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis.pdf
- Size:
- 330.66 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: